Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | IAPP | P10997 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CD44 | P16070 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8295301 | 0.83 | MAPT (0.40) | CYP3A4TSHRALDH1A1IAPPLMNA | |
| SCHEMBL14448435 | 0.80 | IAPP (0.47) | IAPPLMNAMAPTKDM4E | |
| SCHEMBL16507826 | 0.79 | CD44 (0.41) | TSHRALDH1A1IAPPLMNAMAPT | |
| SCHEMBL15949912 | 0.79 | CA1 (0.50) | CYP3A4TSHRPIK3CALMNAMAPT | |
| SCHEMBL19732049 | 0.77 | KDM4E (0.51) | CYP3A4ALDH1A1LMNAMAPTKDM4E | |
| SCHEMBL8661727 | 0.76 | MAPT (0.47) | CYP3A4ALDH1A1IAPPLMNAMAPT | |
| SCHEMBL13210354 | 0.74 | CYP3A4 (0.48) | CYP3A4TSHRPIK3CAALDH1A1CD44 | |
| SCHEMBL8349013 | 0.73 | TSHR (0.45) | TSHRALDH1A1IAPPLMNAMAPT | |
| SCHEMBL2961735 | 0.73 | TSHR (0.45) | TSHRALDH1A1IAPPLMNAMAPT | |
| SCHEMBL1123463 | 0.72 | CYP3A4 (0.56) | CYP3A4TSHRPIK3CAALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3998070-A1 | MIR-124 AS A BIOMARKER FOR THE TREATMENT OF INFLAMMATORY DISEASES | ABIVAX (FR) | 2022-05-18 | — | — | EP | disclosed |